Introduction
During recent years, several methods have been developed to specifically reveal endothelial cells in tissue sections. Such methods include monoclonal antibodies (MAb) raised against endothelial cells [(1-5) ; for review see (6)], or against components present only in endothelial cells, such as factor VIII-related antigen (FVIIIR:Ag) (6,7) or angiotensin-converting enzyme (8). In addition, MAb raised against other tissue components have revealed that surface glycoproteins ofglomerular epithelial cells (9,10) and leukocytes (11) (12) (13) may also be specifically expressed in endothelial cells.
The ABH blood group antigens, defined by carbohydrate detenminants, have been shown to be expressed in kidney endothelial cells with the respective blood group status [e.g. (14,15) endothelial cells in tissues of various species. A few years ago, the UEA-I conjugates, specific for some a-L-fucosyl residues and reacting also with the H blood group substance, were shown to bind to endothelial cells in human tissues, including endothelial tumors (18) (19) (20) .
Since that time, UEA-I conjugates have been applied in many studies as markers for endothelial cells both in vivo and in vitro (6, 21, 22 
Results

Binding of the PTh Conjugates to Tissue Sections
The cells at the sinusoidal lining, in addition to prominent reaction with endothelial cells in the small blood vessels. (e) In spleen, the sinusoidal lining cells in red pulp reacted with Flit-PTA, whereasthe cells in the white pulp lacked reaction.
(1) In the cortical region ofthe adrenal gland, FITC-PTA reacted with many capillaries between tubules. (g) Thyroid follicles showed no reaction, while Flit-PTA bound prominently to all blood vessel endothelia and weakly to some epithelia between follicles. (h) In prostate the endothelia reacted strongly with P-PTA, whereas part of the acinar epithelia showed no reaction. Bars = 50 pm. In the more extensively vascularized full-term placenta (40 weeks), FITC-PTA reactivity also was confined to endothelia (C, Figure  3h ).
In lung tissue, P-PTA reacted with blood vessels, including alveolar capillaries (Figure 4a ), but also with the bronchial basement membrane and bronchial goblet cells (not shown).
In the intestine ( Figure  4b) , binding ofFIlt-PTA was confined to endothelia and epithelial reactivity was not noted. In stomach, Flit-PTA reacted with surface mucous cells and mucous neck cells both in antru'm ( Figure  4c ) and in fundic glands, in addition to a prominent endothelial reactivity. Furthermore, in fundus a weak, finely granulan cytoplasmic reactivity for Flit-PTA was noted deeper in the 
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LAITINEN, HORMIA, VIRTANEN glands, in zymogenic cells ( Figure  4d ). In colon, the goblet cells in glands also showed a regionally highly variable binding of the PTA conjugates with FIIt-PTk ( Figure  4f ). In submandibular salivary gland, Flit-PTA reacted strongly with ductal epithelial cells and luminally with acinarcells, and also bound strongly to endotheha. The epithelial reactivity in salivary gland was distinctly more limited than the reactivity revealed by TRIIC-UEA-I as seen in double staining( Figure  4g ). In addition, the endothelial reactivity with Lane 3), as was also the case when the PTA beads were preincubated with 0.1 M GaINAc ( Figure  6 , Lane 4). 
Discussion
